Trademark: 90188961
Word
GALECTO
Status
Registered
Status Code
700
Status Date
Tuesday, September 28, 2021
Serial Number
90188961
Registration Number
6497206
Registration Date
Tuesday, September 28, 2021
Mark Type
4000
Filing Date
Thursday, September 17, 2020
Published for Opposition
Tuesday, July 13, 2021

Trademark Owner History
Galecto Biotech AB - Original Registrant

Classifications
5 Pharmaceutical, medical and veterinary medicinal products for treatment of cancer, fibrotic diseases, autoimmune disease, neurodegenerative diseases, viral infections, acute inflammatory conditions, transplant rejection
42 Providing medical research information, namely, biological, chemical, pharmaceutical and clinical data in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for treatment of cancer, fibrotic diseases, autoimmune diseases, neurodegenerative diseases, viral infections, acute inflammatory conditions, transplant rejection, and indications hereof

Trademark Events
Sep 28, 2021
Registered-Principal Register
Jul 13, 2021
Official Gazette Publication Confirmation E-Mailed
Jul 13, 2021
Published For Opposition
Jun 23, 2021
Notification Of Notice Of Publication E-Mailed
Jun 9, 2021
Approved For Pub - Principal Register
Jun 9, 2021
Teas/Email Correspondence Entered
Jun 9, 2021
Correspondence Received In Law Office
Jun 7, 2021
Assigned To Lie
Mar 10, 2021
Teas Response To Suspension Inquiry Received
Feb 9, 2021
Notification Of Letter Of Suspension E-Mailed
Feb 9, 2021
Letter Of Suspension E-Mailed
Feb 9, 2021
Suspension Letter Written
Feb 9, 2021
Examiner's Amendment Entered
Feb 9, 2021
Notification Of Examiners Amendment E-Mailed
Feb 9, 2021
Examiners Amendment E-Mailed
Feb 9, 2021
Examiners Amendment -Written
Feb 1, 2021
Assigned To Examiner
Oct 27, 2020
New Application Office Supplied Data Entered In Tram
Sep 24, 2020
Teas Amendment Entered Before Attorney Assigned
Sep 24, 2020
Teas Voluntary Amendment Received
Sep 21, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24